GetTopicDetailResponse(id=9b7d8e4574, topicName=HER3, introduction=HER3, content=null, image=null, comments=0, allHits=855, url=https://h5.medsci.cn/topic?id=8745, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=53845, tagList=[TagDto(tagId=53845, tagName=HER3)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2272883, encodeId=b0c622e288375, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a> <a href='/topic/show?id=3cf38e4696' target=_blank style='color:#2F92EE;'>#HER3抑制劑#</a> <a href='/topic/show?id=9b7d8e4574' target=_blank style='color:#2F92EE;'>#HER3#</a>, objectTitle=JCO：HER3的ADC藥物patritumab deruxtecan對多次治療失敗NSCLC患者，86%肺癌患者腫瘤縮??！, objectType=article, longId=886183, objectId=3ffb88618377, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20250702/fe4cce0f2db645e5bef1dcedf4bd71c0-TK8hr7gAvoD8.jpg, objectUrl=/article/show_article.do?id=3ffb88618377, replyNumber=0, likeNumber=23, createdTime=2025-07-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=3ffb88618377, moduleTitle=JCO：HER3的ADC藥物patritumab deruxtecan對多次治療失敗NSCLC患者，86%肺癌患者腫瘤縮?。? moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ffb88618377)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2254249, encodeId=0404225424932, content=<a href='/topic/show?id=9b7d8e4574' target=_blank style='color:#2F92EE;'>#HER3#</a> <a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=上皮性卵巢癌的新興靶點(diǎn)HER3表達(dá)：卵巢黏液性癌、透明細(xì)胞癌以及復(fù)發(fā)患者潛在獲益, objectType=article, longId=865158, objectId=36328651588c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=36328651588c, replyNumber=0, likeNumber=0, createdTime=2025-03-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=36328651588c, moduleTitle=上皮性卵巢癌的新興靶點(diǎn)HER3表達(dá)：卵巢黏液性癌、透明細(xì)胞癌以及復(fù)發(fā)患者潛在獲益, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=36328651588c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
